1. Home
  2. DYAI vs VBIX Comparison

DYAI vs VBIX Comparison

Compare DYAI & VBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • VBIX
  • Stock Information
  • Founded
  • DYAI 1979
  • VBIX N/A
  • Country
  • DYAI United States
  • VBIX Israel
  • Employees
  • DYAI N/A
  • VBIX N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • VBIX Computer Software: Prepackaged Software
  • Sector
  • DYAI Health Care
  • VBIX Technology
  • Exchange
  • DYAI Nasdaq
  • VBIX Nasdaq
  • Market Cap
  • DYAI 28.3M
  • VBIX 26.4M
  • IPO Year
  • DYAI 2004
  • VBIX N/A
  • Fundamental
  • Price
  • DYAI $1.13
  • VBIX $5.27
  • Analyst Decision
  • DYAI Strong Buy
  • VBIX
  • Analyst Count
  • DYAI 1
  • VBIX 0
  • Target Price
  • DYAI $6.00
  • VBIX N/A
  • AVG Volume (30 Days)
  • DYAI 203.9K
  • VBIX 111.2K
  • Earning Date
  • DYAI 08-12-2025
  • VBIX 08-14-2025
  • Dividend Yield
  • DYAI N/A
  • VBIX N/A
  • EPS Growth
  • DYAI N/A
  • VBIX N/A
  • EPS
  • DYAI N/A
  • VBIX N/A
  • Revenue
  • DYAI $3,554,344.00
  • VBIX $19,672,000.00
  • Revenue This Year
  • DYAI $22.56
  • VBIX N/A
  • Revenue Next Year
  • DYAI $30.95
  • VBIX N/A
  • P/E Ratio
  • DYAI N/A
  • VBIX N/A
  • Revenue Growth
  • DYAI 57.59
  • VBIX N/A
  • 52 Week Low
  • DYAI $0.91
  • VBIX $2.42
  • 52 Week High
  • DYAI $2.20
  • VBIX $12.00
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 62.78
  • VBIX N/A
  • Support Level
  • DYAI $1.08
  • VBIX N/A
  • Resistance Level
  • DYAI $1.20
  • VBIX N/A
  • Average True Range (ATR)
  • DYAI 0.08
  • VBIX 0.00
  • MACD
  • DYAI 0.02
  • VBIX 0.00
  • Stochastic Oscillator
  • DYAI 50.00
  • VBIX 0.00

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About VBIX Viewbix Inc. Common Stock

ViewBix Inc operates in the field of digital advertising. Along with its subsidiaries, the company performs two main activities that are reported as separate operating segments: the search segment and the digital content segment. Maximum revenue is generated from the digital content segment, which is engaged in the creation and editing of content, in different languages, for different target audiences, to generate revenues from advertising platforms, including Google, Facebook, Yahoo, and Apple, by utilizing such content to obtain internet user traffic for its customers. The search segment develops various technological software solutions, which perform automation, optimization, and monetization of internet campaigns, to obtain and route internet user traffic to its customers.

Share on Social Networks: